The conference is designed to cover a broad spectrum of contemporary issues within the field of biotechnology. Some specific topics in the program include monoclonal antibody formulation, stem cell therapy, nucleic acid therapeutics, protein glycosylation, biophysical characterization, nanomedicine, preformulation, immunogenicity of biotechnology products, PK/PD modeling of monoclonal antibodies, bioanalytical methods for follow-on biologics (biogenerics), cellular drug delivery and global outsourcing of biopharmaceuticals. This timely conference will provide a forum for individuals from industry, government, and academia to present and discuss the challenges facing this rapidly growing sector of the pharmaceutical industry. The scientific program is comprised of a combination of in-depth oral presentations, workshops, and poster sessions. Preceeding the conference there will be an open forum focused on Aggregation of Protein Therapeutics. A short course on Development of PEGylated Biopharmaceuticals and a workshop on Nasal and Pulmonary Delivery will also be held in conjunction with the meeting. A preliminary program as well as information on the conference venue and registration procedures may be found at www.aapspharmaceutica.com/nationalbiotech. 
